Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels.
Age is a powerful predictor of survival in glioblastoma multiforme (GBM) yet the biological basis for the difference in clinical outcome is mostly unknown. Discovering genes and pathways that would explain age-specific survival difference could generate opportunities for novel therapeutics for GBM....
| Published in: | PLoS ONE |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Online Access: | http://europepmc.org/articles/PMC3639162?pdf=render |
